Oral Drug Delivery Resources

  1. Rational Design Of Oral Nanosuspensions For Insoluble Drugs 1/26/2022

    The advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.

  2. 3D Printing Of Pharmaceutical Dosage Forms – Has The Time Come? 10/27/2022

    Additive manufacturing, or 3D printing, is arguably balancing on the cusp of translation from academic research into industry practice for pharmaceuticals. What will the future impact of 3D printing be?

  3. Patient-Centric Formulations In Pediatric Adherence 11/13/2025

    Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

  4. Choosing A Formulation And Process Approach To OCR Products 11/5/2018

    Do you want to develop an oral controlled release (OCR) product? Understand the options and their ramifications as the first step toward devising a plan.

  5. Age-Appropriate Pediatric Formulation Development 1/27/2022

    There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.

  6. Benefits Of Microparticle Technology For Oral Drug Solubility Enhancement 6/8/2022

    Spray-dried dispersions, hot-melt extrusion, and solubilizing excipients are common solubility enhancement techniques, but new developments to maximize amorphous solid dispersion benefits are needed.

  7. Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing 6/30/2025

    Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

  8. Reshaping Drug Development With 3D Screen Printing 8/15/2025

    Steven Facer and Laxxon Medical COO Klaus Kühne describe the capabilities of 3D screen printing for pharmaceutical production. Explore prototyping, IP protection, release profile possibilities, and more.

  9. Reformulation Of A Complex, High-Drug-Load, Modified Release Dosage Form 4/5/2021

    What if you could limit and position a formulation change as only a CMC prior approval supplement under the FDA’s scale-up and post-approval changes guidance?

  10. Patient Adherence With A Novel Dosage Form 11/13/2025

    A sprinkle formulation helps patients with tremors or dysphagia take medication more easily, improving adherence, comfort, and care through a novel, FDA-approved oral granule format.